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Faecal miRNA profiles associated 
with age, sex, BMI, and lifestyle 
habits in healthy individuals
Antonio Francavilla1,2,8, Amedeo Gagliardi1,2,8, Giulia Piaggeschi1,2,8, Sonia Tarallo1,2, 
Francesca Cordero3, Ruggero G. Pensa3, Alessia Impeduglia3, Gian Paolo Caviglia4, 
Davide Giuseppe Ribaldone4, Gaetano Gallo5, Sara Grioni6, Giulio Ferrero3,7,8, 
Barbara Pardini1,2,8 & Alessio Naccarati1,2,8*
For their stability and detectability faecal microRNAs represent promising molecules with potential 
clinical interest as non-invasive diagnostic and prognostic biomarkers. However, there is no evidence 
on how stool miRNA profiles change according to an individual’s age, sex, and body mass index (BMI) 
or how lifestyle habits influence the expression levels of these molecules. We explored the relationship 
between the stool miRNA levels and common traits (sex, age, BMI, and menopausal status) or 
lifestyle habits (physical activity, smoking status, coffee, and alcohol consumption) as derived by a 
self-reported questionnaire, using small RNA-sequencing data of samples from 335 healthy subjects. 
We detected 151 differentially expressed miRNAs associated with one variable and 52 associated with 
at least two. Differences in miR-638 levels were associated with age, sex, BMI, and smoking status. 
The highest number of differentially expressed miRNAs was associated with BMI (n = 92) and smoking 
status (n = 84), with several miRNAs shared between them. Functional enrichment analyses revealed 
the involvement of the miRNA target genes in pathways coherent with the analysed variables. Our 
findings suggest that miRNA profiles in stool may reflect common traits and lifestyle habits and 
should be considered in relation to disease and association studies based on faecal miRNA expression.
In the last years, an increasing interest in understanding how individuals’ behaviour can affect human health has 
been witnessed. Environmental factors such as diet, physical activity, smoking habits, and alcohol consumption, 
in addition to individual traits, including sex, age, and Body Mass Index (BMI), have been established as risk 
factors for many diseases, including neurodegenerative and metabolic disorders, as well as  cancer1. However, 
the molecular mechanisms behind these relationships have not been exhaustively  clarified2. Epigenetic modifi-
cations, such as DNA methylation, histone acetylation, nucleosome positioning, and alteration of non-coding 
RNA profiles are some of the modalities whereby the environment affects gene expression and ultimately impacts 
individuals’  health3. Among the wide range of non-coding RNA molecules, small non-coding RNAs (sncRNAs) 
represent a promising subclass of great interest for their potential clinical applications in the diagnosis and 
therapies of several  diseases4. microRNAs (miRNAs), the most studied sncRNAs, post-transcriptionally regulate 
many messenger RNAs with the primary function of fine modulation of gene expression, thus affecting many 
physiological and developmental  processes5. These molecules are stable and easily detectable in various human 
biospecimens, including biofluids and, combined with the fact that they are dysregulated in several diseases, 
they represent ideal candidates as non-invasive  biomarkers6, 7. These aspects explain the impressive research on 
miRNAs over the last years in biomedicine.
In contrast, the relationships between miRNAs and individual traits/lifestyle factors have not been explored 
at the same pace. So far, most of the studies have evaluated miRNA expression levels in relation to age, sex, and 
BMI almost exclusively in whole-blood, plasma, or  serum8–12. The influence of smoking on miRNA expression 
has also been frequently studied. Indeed, miRNAs resulted dysregulated in plasma, peripheral blood cells, and 
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human airway epithelium of both current and former smokers compared to non-smokers healthy  subjects13–15. 
On the other hand, the effect of physical activity on circulating miRNA levels has been mainly investigated in 
intervention  studies16, 17. Very little is known regarding the impact of other important lifestyle habits such as 
alcohol or coffee consumption on miRNA expression levels in healthy subjects. To the best of our knowledge, 
only one study investigated the effects of alcohol intake on miRNA expression levels in healthy  volunteers18 while 
no study focused on coffee intake, although this beverage is largely consumed worldwide and is widely studied 
in relation to cancer and other  diseases19–21. Apart from a few  exceptions17, all the available studies presented 
some limitations, such as the small number of subjects investigated and/or a limited number of miRNAs analysed 
(mainly evaluated by arrays and/or RT-qPCR).
Among the biospecimens where miRNAs can be detected, stool are emerging as a relevant surrogate tissue 
for the non-invasive diagnosis of gastrointestinal  disorders22–24. Exploring faecal miRNAs has several positive 
aspects: miRNAs from exfoliated colonocytes are directly and continuously released into the intestinal lumen 
being easily detectable in faecal samples with a minimal  invasiveness25. Importantly, recent discoveries high-
lighted an interplay between faecal miRNAs and human microbiota, whose composition varies in relation to 
different lifestyles and gastrointestinal  conditions22, 23, 26. In this respect, clarifying the relationship between stool 
miRNA expression levels and common traits and lifestyle habits may be  essential27.
In the present study, we investigated miRNA expression levels by small RNA sequencing (sRNA-seq) in stool 
of 335 healthy volunteers in relation to sex, age, BMI, smoking, alcohol and coffee consumption, and physical 
activity to understand their possible modulatory effects on the human faecal miRNome. We found several miR-
NAs associated with one or more of the investigated variables, with the largest number of differentially expressed 
miRNAs (DEmiRNAs) in relation to BMI, smoking, and coffee consumption. Overall, our findings revealed 
considerable relationships which should be considered in stool miRNA-based biomarkers research studies in 
the context of personalised medicine.
Results
Study population. A total of 342 faecal samples were collected from healthy subjects recruited in different 
studies. Six subjects provided a second stool sample one year after the first collection: for them, only data from 
the first sampling were considered in the analyses while the second sample was used to assess intra-individual 
variability. One subject was excluded because few sRNA-Seq reads were aligned on miRNA sequences. The final 
study population consisted of 335 subjects provided by both stool sRNA-seq data and lifestyle questionnaires 
(Fig. 1). Subjects had an average age of 44.7 ± 14.7 years old (range: 18–81) and 63.6% were females (Table 1).
Stool miRNA profiles and analysis of the intra/inter-individual expression variability. On aver-
age, 10.3 million single-end reads per sample were obtained from sRNA-Seq with a median of 64,281 reads 
(0.92%) assigned to human miRNA annotations (Supplementary Table 1A). In total, 3,277 miRNAs (93% of 
our miRNA reference) were detected in at least one subject, but an extensive variability was observed among 
individual miRNA profiles (ranging from 188 to 1,949 detected miRNAs per sample), with a median of 594 
miRNAs detected in stool of the studied population. The chromosomal distribution of all the stool miRNAs 
detected was compared with that of the total reference miRNome investigated (n = 3,524): an average of 93.7% of 
detected miRNAs per chromosome was observed, with the highest percentage on chromosome Y and the lowest 
on chromosome 2 (100% and 88.2% of the total miRNA coding genes, respectively; Supplementary Table 1B).
Four hundred and forty-nine miRNAs (13.8%) were detected in at least half of the analysed samples (Sup-
plementary Table 1B). Among them, nine miRNAs (miR-320e-5p, miR-607, miR-647-3p, miR-1246-3p, miR-
1302, miR-3125, miR-5698, miR-6075, and miR-6777-5p) were detected in all the samples analysed. miR-3125 
was characterised by the highest median expression levels (2,051 reads), followed by miR-6075 (921 reads), and 
miR-1246-3p (884 reads).
To evaluate the inter-individual variability of stool miRNA expression levels across the study population, a 
coefficient of variation (CV) was calculated for all miRNAs with a median read expression level of at least one 
(n = 2,031). The resulting coefficients were used to rank miRNAs according to their expression variability (Sup-
plementary Table 1C). miR-647-3p, miR-6075, and miR-3125, also expressed in all samples, showed the lowest 
expression variability (CV ranging from 0.48 to 0.50, Fig. 2a).
Repeated samples collected from six subjects were used to assess the stability of stool miRNA expression levels 
over time. A second faecal sample was collected approximately one year after the first collection (min = 378 days, 
max = 560 days). No significant changes in lifestyle habits were reported from the questionnaires compiled by 
the participants on both occasions. A Spearman correlation analysis between miRNA expression levels at the 
two time points showed a correlation coefficient ranging from 0.54 (p < 0.001) to 0.72 (p < 0.0001) (Fig. 2b). A 
Wilcoxon paired test performed on the set of nine miRNAs detected in all samples showed that they were also 
expressed in the repeated samples and did not show any significant difference in mean expression levels (p > 0.05), 
except for miR-3125 (Supplementary Table 1D).
miRNA profiles in relation to common traits. miRNA expression levels were explored in relation to 
sex, age, menopausal status, and BMI. Initially, miRNA profiles of 122 males and 213 females were compared 
and nine DEmiRNAs were observed between sexes (Supplementary Table 2). Specifically, five were up-regulated 
(miR-324-3p, miR-324-5p, miR-1255b-5p, miR-3935, and miR-4675) and four down-regulated (miR-3615-5p, 
miR-4326, miR-4418, and miR-4632-5p) in males. The expression levels of miR-324-5p, miR-4326, and miR-
4418 are reported as an example of DEmiRNAs associated with sex (Fig. 3a).
Considering the age distribution of the study population, miRNA profiles were investigated comparing three 
categories: < 37 (n = 122), 37–53 (n = 111), and > 53 (n = 102) years old. In total, 19 DEmiRNAs were identified 
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in at least one comparison among these categories (Supplementary Table 2). miR-1231 and miR-4276-3p were 
down-regulated and miR-4487 was up-regulated in subjects of the age class 37–53 compared with those of the age 
class < 37. Comparing subjects of age class > 53 with those of the class < 37, 7 DEmiRNAs (6 down- and miR-3169 
up-regulated in the older group) were identified. Between the age classes 37–53 and > 53, 10 DEmiRNAs (3 down- 
and 7 up-regulated in the eldest group) were identified. Progressive reduced expression levels with increasing 
age were observed across categories for miR-4276-3p and increased for miR-3169 and miR-4505-3p (Fig. 3b).
For the 19 DEmiRNAs, a similar expression pattern among age classes was observed when the analysis was 
performed considering males and females separately (Supplementary Table 2). However, only miR-550a-3-5p was 
significantly down-regulated in males of the age class 37–53 with respect to the other two classes. Additionally, 
13 and 6 DEmiRNAs were specifically associated with age in males and females, respectively (Supplementary 
Table 2).
The relationship between stool miRNA expression levels and age was also explored by Spearman correlation 
analysis, considering the whole study population or stratified by sex. In the whole population, four miRNAs 
(miR-922, miR-3619-3p, miR-4276-3p, and miR-8074) decreased with age (-0.26 < SCC < -0.19; adj. p < 0.05). In 
Figure 1.  Workflow of the study.
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females, the expression of miR-8074 was inversely correlated with age (SCC = -0.28, adj. p < 0.001) while in males 
no significant correlation was found (Supplementary Table 3).
Stool miRNA expression levels of women in premenopausal status (n = 132) were compared with those in 
post menopause (n = 77). Only miR-3615-5p was significantly down-regulated in postmenopausal women (Sup-
plementary Table 2). This miRNA was also significantly more expressed in females compared to men.
miRNA levels in relation to BMI were assessed comparing obese (n = 18), overweight (n = 66), and under-
weight (n = 25) individuals with normal weight subjects (n = 215). A total of 92 miRNAs were significantly 
Table 1.  Study population characteristics. *BMI was categorized according to the World Health Organization 
guidelines as underweight (< 18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2) and 
obese (30.0–34.9 kg/m2). **Alcohol consumption was categorized according to the alcohol intake measured 
in gr/day: non-drinkers (0 gr/day), low intake drinkers (< 24 gr/day for males and < 12 gr/day for females) 
and high intake drinkers (> 24 gr/day for males and > 12 gr/day for females). ***Coffee consumption was 
categorized according to the coffee intake measured in g/day: non-drinkers (0 gr/day), low intake drinkers 
(1–16 gr/day) and high intake drinkers (> 16 gr/day).
Female (N = 213) Male (N = 122) Overall (N = 335)
Age years
Mean ± SD 43.9 ± 14.5 46.1 ± 15.0 44.7 ± 14.7
Median [Min, Max] 44.0 [18.0, 80.0] 48.0 [19.0, 81.0] 45.0 [18.0, 81.0]
Age tertiles (%)
18–37 84 (39.4%) 38 (31.1%) 122 (36.4%)
37–53 66 (31.0%) 45 (36.9%) 111 (33.1%)
53–81 63 (29.6%) 39 (32.0%) 102 (30.5%)
BMI*
Mean ± SD 22.4 ± 3.7 24.5 ± 3.6 23.1 ± 3.8
Median [Min, Max] 21.9 [15.4, 39.9] 24.1 [17.2, 35.8] 22.6 [15.4, 39.9]
Missing (%) 5 (2.3%) 6 (4.9%) 11 (3.3%)
BMI Classes (%)*
Underweight 23 (10.8%) 2 (1.6%) 25 (7.5%)
Normal 145 (68.1%) 70 (57.4%) 215 (64.2%)
Overweight 32 (15.0%) 34 (27.9%) 66 (19.7%)
Obese 8 (3.8%) 10 (8.2%) 18 (5.4%)
Missing 5 (2.3%) 6 (4.9%) 11 (3.2%)
Smoking status (%)
Current smoker 37 (17.4%) 20 (16.4%) 57 (17.0%)
 < 16 cigs/day 28 (13.1%) 13 (10.6%) 41 (12.2%)
 > 16 cigs/day 9 (4.2%) 7 (5.7%) 16 (4.8%)
Former smoker 50 (23.5%) 44 (36.1%) 94 (28.1%)
Never smoker 125 (58.7%) 56 (45.9%) 181 (54.0%)
Missing 1 (0.4%) 2 (1.6%) 3 (0.9%)
Alcohol consumption (%)**
Non drinkers 23 (10.8%) 6 (4.9%) 29 (8.7%)
Low intake drinkers 151 (70.9%) 79 (64.8%) 230 (68.7%)
High intake drinkers 38 (17.8%) 37 (30.3%) 75 (22.4%)
Coffee consumption (%)***
Non drinkers 89 (41.8%) 46 (37.7%) 135 (40.3%)
Low intake drinkers 96 (45.1%) 53 (43.4%) 149 (44.5%)
High intake drinkers 27 (12.7%) 23 (18.9%) 50 (14.9%)
Physical activity (%)
Active 14 (6.6%) 7 (5.7%) 21 (6.3%)
Moderately active 63 (29.6%) 45 (36.9%) 108 (32.2%)
Moderately inactive 72 (33.8%) 42 (34.4%) 114 (34.0%)
Inactive 63 (29.6%) 27 (22.1%) 90 (26.9%)
Missing 1 (0.4%) 1 (0.9%) 2 (0.6%)
Menopausal status (%)
Premenopausal 132 (62.0%) - -
Postmenopausal 77 (36.2%) - -
Missing 4 (1.8%) - -
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differentially expressed in at least one comparison (Supplementary Table 2). In the obese group, ten and eight 
miRNAs were respectively up- and down-regulated, 69 miRNAs (64 down- and five up-regulated) were altered 
in the overweight group, and, finally, in the underweight group, 18 DEmiRNAs (13 down- and 5 up-regulated) 
were identified. Many of the DEmiRNAs showed a trend of expression going from underweight to obese, includ-
ing miR-194-3p, miR-200b-3p, and miR-4748-3p (Fig. 3c and Supplementary Table 2).
Stratifying for sex, the 92 above mentioned DEmiRNAs showed a coherent trend of expression either in 
males or in females (Supplementary Table 2) with 4 and 18 DEmiRNAs also significant in males and females, 
respectively. Additional differentially expressed miRNAs were found in males (n = 4) or females (n = 33) only.
The stool miRNA expression profiles according to BMI (considered as a continuous variable) were further 
investigated by Spearman correlation analysis. With an increasing BMI, the expression levels of 22 miRNAs 
significantly decreased (-0.16 < SCC < -0.24, adj. p < 0.05) while 4 miRNAs increased (-0.22 < SCC < 0.17, adj. 
p < 0.05) (Supplementary Table 3). Twenty out of the 26 miRNAs significantly correlated with BMI were also 
differentially expressed among the BMI groups. No significant correlations were observed after the stratification 
for sex.
miRNA profiles according to lifestyle habits. miRNA levels were further investigated in relation to 
smoking status, alcohol, and coffee consumption as well as physical activity.
For smoking habits, miRNA levels were analysed comparing subjects who smoked more than 16 cigs/day 
(n = 16), those smoking less than 16 cigs/day (n = 41) and former smokers (n = 94) with never smokers (n = 181). 
Overall, 84 DEmiRNAs were identified from the three comparisons (Supplementary Table 2). Comparing indi-
viduals who smoke more than 16 cigs/day with non-smokers, 59 DEmiRNAs were identified (50 up- and nine 
down-regulated) while 22 miRNAs were differentially expressed in those who smoke less than 16 cigs/day 
compared to non-smokers (three up- and 19 down-regulated). Interestingly, mir-8075-5p and miR-12128 were 
down-regulated in both smoking categories compared to non-smokers. Finally, 13 miRNAs were differentially 
expressed in former smokers vs non-smokers, with miR-5090-3p up-regulated and the other 12 DEmiRNAs 
down-regulated in the former group. Some of the 84 DEmiRNAs associated with smoking showed a trend of 
expression from non-smoker individuals to those who smoke more than 16 cigs/day (Supplementary Table 2). 
miR-302c-5p, miR-4508-3p and miR-6745-5p are reported in Fig. 4a as examples of such trends.
A similar expression pattern was observed for the 84 DEmiRNAs when the population was stratified by sex, 
with 14 and 26 out of 84 DEmiRNAs significantly dysregulated in men and women, respectively. Other additional 
sex-specific DEmiRNAs were uniquely identified in men (n = 17) and women (n = 14) (Supplementary Table 2).
The relationship between miRNA expression levels and alcohol consumption was assessed comparing non-
drinkers (n = 29) with low (n = 230) and high (n = 75) intake drinkers. Comparing high intake drinkers with 
Figure 2.  (a) Scatter plot showing the stool miRNA inter-individual variability expressed as a relation between 
median expression levels and coefficient of variation (CV). Red dots represent miRNAs detected in all samples. 
On the left of the dotted line are reported those miRNAs characterised by the lowest CV. (b) Scatter plots 
showing the stool miRNA intra-individual variability of four selected subjects who provided a stool sample at 
two different time points.
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non-drinkers, miR-3972 was down-regulated in the latter, whereas in low intake drinkers vs non-drinkers, 
miR-4254 and miR-4254-5p were down-regulated, and miR-6895-3p up-regulated in drinkers. The expression 
levels of miR-3972, miR-4254, and miR-4254-5p, characterised by a trend of expression in non-drinkers, low, 
and high intake drinkers, are reported in Fig. 4b. The aforementioned 4 alcohol-related DEmiRNAs showed a 
similar trend of expression also stratifying by sex, with miR-4254 and miR-3972 being significant in males and 
miR-4254-5p and miR-6895-3p in females. Moreover, other eight DEmiRNAs were uniquely observed in males 
and 11 in females in both drinking categories vs non-drinkers.
miRNA profiles in relation to coffee consumption were studied comparing low (n = 149) and high (n = 50) 
intake coffee drinkers with non-drinkers (n = 135). In high intake coffee consumers vs non-drinkers, 44 miRNAs 
were differentially expressed, with three up- and 41 down-regulated, in drinkers (Supplementary Table 2). Five 
out of these 44 miRNAs were also differentially expressed with the same expression trend in low coffee drinkers 
compared to non-drinkers: miR-1281 was up-regulated and miR-622, miR-1231, miR-7515-5p, and miR-8053 
were down-regulated in drinkers. Three miRNAs characterised by decreasing expression levels going from non-
drinkers to high drinker subjects are reported in Fig. 4c.
Performing the same comparisons and stratifying the population according to sex, similar trends of expres-
sion were observed for the 44 DEmiRNAs previously reported. Two additional miRNAs in males and seven in 
females were uniquely identified (Supplementary Table 2).
The stratification of the study population according to the physical activity identified the following categories: 
inactive (n = 90), moderately inactive (n = 114), moderately active (n = 108), and active (n = 21) subjects. Compar-
ing each of the first three categories against active individuals, 11 DEmiRNAs were identified (Supplementary 
Table 2). Six miRNAs, five down- and one up-regulated (miR-182-3p), resulted from the comparison between 
inactive vs active subjects. Also six DEmiRNAs (two up- and four down-regulated) were found in moderately 
inactive individuals and, finally, seven miRNAs (four up- and three down-regulated) in those moderately active. 
Two DEmiRNAs (miR-4493 and miR-4700-5p) with significant increasing expression levels in the active category 
and miR-646 with a mild trend of up-regulation going from inactive to the active group are reported in Fig. 4d.
Figure 3.  (a–c) Box plots showing the expression levels of selected differentially expressed miRNAs among 
individuals stratified according to the investigated common trait: sex (a), age (b), and BMI (c). P-values were 
computed by DESeq2 and adjusted using the FDR method. ***adj.p < 0.001, **adj.p < 0.01, *adj.p < 0.05.
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The same comparisons were also performed stratifying according to sex, confirming similar trends of expres-
sion for the 11 DEmiRNAs in both males and females. However, among them, miR-646, miR-5090-3p, and 
miR-12121 were found significantly altered in females and just miR-4700-5p altered in males. Additionally, eight 
DEmiRNAs were found only in males (n = 4) or females (n = 4) (Supplementary Table 2).
Overview of common miRNAs altered among investigated variables. From a total of 3,041 miR-
NAs detected, 151 (5%) were associated with at least one of the analysed common traits or lifestyle habits while 
52 DEmiRNAs were significant in two or more comparisons (Supplementary Table 2). Considering separately 
for males and females the stool levels of the latter group of DEmiRNAs, a subtle clustering of miRNAs emerged 
for both sexes, mainly related to smoking habit, BMI and coffee consumption, as reported in the heatmap in 
Fig. 5.
To test the temporal stability of all the identified stool DEmiRNAs expression levels in repeated samples col-
lected from the same individuals, a Wilcoxon paired test was performed between the available samples collected 
at two time points. One hundred and seventy-three miRNAs (85.2%) showed no significant variation between 
the two measurements (p ≥ 0.05, Supplementary Table 1D). The remaining 30 DEmiRNAs (among which two 
variables shared 11 miRNAs), showing a significant variability between the two time points, were mostly related 
to BMI (n = 13), smoking habit (n = 14) or coffee consumption (n = 11).
Target gene enrichment analysis. Functional enrichment analysis was performed to explore whether 
independent sets of faecal DEmiRNAs identified in this study were involved in relevant biological processes 
for the investigated variables. The analysis, carried out considering the validated target genes of DEmiRNAs, 
revealed a total of 298 significantly enriched terms (Supplementary Table 4). Two hundred and eleven, six and 
81 terms were enriched for GO, KEGG, and REACTOME gene set libraries, respectively. An overlap of five 
REACTOME enriched terms among different variables was observed and reported in Supplementary Table 4.
Figure 4.  (a–d) Box plots showing the expression levels of selected DEmiRNAs among individuals stratified 
according to the investigated lifestyle habits: smoking status (a), alcohol (b) or coffee (c) consumption, and 
physical activity (d). P-values were computed by DESeq2 and adjusted using the FDR method. ***adj.p < 0.001, 
**adj.p < 0.01, *adj.p < 0.05.
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Discussion
An increasing number of observations has highlighted the clinical and nutritional potentialities of stool 
 miRNAs22, 25, 28. However, there is still limited evidence on their expression levels in relation to common traits 
and lifestyle habits in healthy individuals. Our study aimed at filling this gap, providing the first evidence on 
how the faecal miRNome expression is affected by a set of common variables investigated in a population of 335 
healthy subjects. A total of 203 miRNAs were significantly associated with at least one of the considered variables, 
with 52 associated with more than one. Several miRNAs showed a differential expression in agreement with other 
studies on blood or tissue samples 10, 29, 30. For example, differences in miRNA expression levels related to sex have 
been previously reported 27, 29, 31. Interestingly, miR-324-5p, up-regulated in males in our study, was also reported 
up-regulated in healthy brain tissue of males compared to  females29. Enrichment analyses of the validated targets 
of the sex-associated DEmiRNAs showed several enriched terms (Fig. 6 and Supplementary Table 4), including 
metabolic terms such as glucose catabolic process, glycolytic process through fructose 6 phosphate, NR1H2 NR1H3 
regulate gene expression to control bile acid homeostasis, and others linked to the senescence (cell aging, cellular 
senescence) which have already been observed differently regulated according to  sex32, 33.
Alterations in miRNA expression levels associated with aging have also been reported in various 
 biospecimens8, 34. In stool samples, we observed a group of miRNAs affected by aging, with the majority of 
them down-regulated in older subjects. Interestingly, among these miRNAs miR-320d, miR-638, miR-922, miR-
1229-5p, and miR-1231 were found strongly decreased with age in whole blood samples from 1,334 healthy 
individuals by Fehlmann et al.10. Enrichment analysis based on the age-related miRNAs revealed their involve-
ment in cellular sphingolipid homeostasis, CREB phosphorylation, negative regulation of vascular smooth muscle 
cell proliferation, cellular response to reactive nitrogen species and regulation of store operated calcium entry, which 
have all been largely described modulated by  aging35–38 (Fig. 6).
Figure 5.  Heatmap reporting, separately for males and females, the results of the hierarchical clustering of 52 
DEmiRNAs significantly associated with two or more variables. For each DEmiRNA, the z-score of log10 read 
count for each sample is reported.
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To the best of our knowledge, the relationship between menopausal status and miRNA expression levels 
has been investigated only in relation to menstrual cycle disorders or hormones regulation and not in healthy 
 women39–41. We reported, for the first time, one miRNA, miR-3615-5p, down-regulated in faecal samples of 
postmenopausal women. Notably, this miRNA resulted also significantly up-regulated in females compared to 
males and down-regulated with increasing BMI. However, this observation should be carefully considered since 
miR-3615 overlaps the 5’UTR of SLC9A3R1 gene and Kim et al. previously demonstrated that miR-3615 is among 
three miRNAs having a non-canonical biogenesis, i.e., from 5′ capped pre-miRNAs not requiring DROSHA for 
their maturation  process42. Further experiments are needed to clarify the specificity of the observed expression 
of this miRNA in different biospecimens.
Compared to sex and age, we observed a higher number of faecal miRNAs associated with BMI. Many stud-
ies reported circulating miRNA dysregulation in relation to BMI, mainly focusing on overweight and obesity 
conditions in which most of the described DEmiRNAs were down-regulated. Such evidence highlighted the 
involvement of miRNAs in BMI-related pathways such as adipogenesis, insulin resistance and fatty acid and 
cholesterol  metabolism43. In this study, 92 miRNAs were reported with variable expression levels according to 
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Figure 6.  Dot plots showing the statistical significance of the GO Biological Process enriched terms considering 
the DEmiRNA validated target genes obtained for each of the analysed variables. The size of the dots is 
proportional to the significance of the enrichment while the number of target genes belonging to each term is 
reported on the x-axis. The colour code refers to the coefficient computed by RBiomirGS. Negative (in blue) and 
positive (in red) coefficients represent processes predicted to be down-regulated or up-regulated, respectively, 
based on the different miRNA expression levels between comparisons.
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described by Ameling et al. in plasma of healthy  individuals11. This miRNA has a role in several cancers as tumor 
 suppressor44–46; however, the literature available reported also its involvement in adipogenesis differentiation, 
obesity-related inflammation and insulin resistance, even if the trend of expression with BMI is not always 
concordant among the  studies47, 48. Functional analysis of the target genes of the 92 DEmiRNAs associated with 
BMI highlighted enriched terms in pathways related to this variable (Fig. 6 and Supplementary Table 4). Among 
these, glucose 6 phosphate metabolic process, NADP metabolic process and negative regulation of amyloid fibril 
formation, which have been largely described in relation to BMI and  obesity49, 50.
Overall, compared to the individual common traits, variables related to lifestyles showed a more substantial 
impact on faecal miRNA expression. Many DEmiRNAs resulted associated with smoking, including miR-21-5p, 
miR-148a-3p, miR-200b-3p, and miR-200c-3p, that were already found altered with similar trends in in vitro 
 studies51, 52. The impact of smoking habit on miRNA expression levels has been reported on plasma, peripheral 
blood mononuclear cells, and small airway epithelium samples, showing a differential expression for several 
miRNAs in smokers compared to non-smokers13–15, 30. In agreement with the present work, a study on whole 
blood from 226 healthy individuals showed an up-regulation of miR-1229-5p and miR-4739 in current smok-
ers compared to  never30. Interestingly, an increased difference in miRNA expression levels was observed when 
smokers were stratified according to the number of cigarettes smoked. This finding suggests that the amount of 
smoking is probably more influential on miRNA levels detectable in stool than the smoking itself. Enrichment 
analysis of the DEmiRNA target genes associated with smoking identified many biological pathways (Fig. 6 
and Supplementary Table 4), including response to corticosterone, involved in the immunosuppressive effect of 
 nicotine53, sensory perception of bitter taste and regulation of RUNX1 expression and activity already described 
in relation to cigarette  smoking54, 55.
The effect of alcohol consumption on miRNA expression has been primarily studied in liver disease and 
 neuroinflammation56–59. However, the relationship between alcohol consumption and miRNA expression levels 
has been scarcely investigated in healthy individuals. One study explored miRNA expression levels before and 
after alcohol consumption in serum samples of healthy young individuals attending a social event. The authors 
observed that 265 miRNAs were up-regulated and miR-185-5p was down-regulated after alcohol  consumption18. 
Analysing our data, we found four miRNAs significantly associated with alcohol consumption, but none of 
them overlapped with those of the previously described study. However, no significant miRNA target enriched 
terms were observed, as well as no other evidence for such miRNAs, highlighting the need for further research 
on this topic.
We also demonstrated a relationship between coffee intake and stool miRNA levels with 84 DEmiRNAs 
comparing high- and low-intake individuals against non-drinkers, with a prevalence of down-regulated miR-
NAs. Previous studies have reported the influence of coffee consumption on miRNA  regulation60, though it is 
still unclear if these effects are due to caffeine itself or the combination with other coffee  compounds61, 62. Target 
functional analyses showed several GO terms related to apoptosis and cell response to stress (Fig. 6 and Sup-
plementary Table 4). This is in line with other studies that have investigated the relationship between caffeine 
and  apoptosis62, 63.
Finally, 11 DEmiRNAs were found associated with a more active lifestyle. Although associations between 
physical activity and miRNA profiles have been already described, no study is available on stool miRNAs. Sev-
eral studies, included in the review from Dufresne and  colleagues64, have suggested that physical activity could 
influence miRNA expression levels in healthy individuals, especially those miRNAs that are muscle-related and 
regulated within muscle tissues (also called myomiRs)65. Functional analyses based on DEmiRNAs related to the 
physical activity revealed among 28 enriched GO terms, 10 involved in the transport, localization, and organiza-
tion of proteins and other cellular components (Fig. 6 and Supplementary table 4). Other pathways were related 
to mitochondrial organization and protein localization in these organelles, confirming an observed relationship 
with physical  exercise66. It is worth pointing out that while most of the studies investigated the effect of physical 
activity on miRNA expression measured after exercise, our samples were collected randomly during the day. 
However, our results suggest that also mild differences in physical activity habits may be reflected in different 
faecal miRNA expression levels, strongly encouraging further analysis on this field with larger cohorts.
Overall, our work highlighted that some of the examined traits differently impact faecal miRNA levels in the 
two sexes. These differences are mainly observable with BMI and lifestyle habits. We cannot firmly claim that 
there is an effective inter-sexual difference since we cannot rule out that these results can be ascribed to the dif-
ferent number of individuals in each category, thus influencing the statistics. Nevertheless, these findings suggest 
the importance of sex as a possible confounder also in miRNA-based studies.
Interestingly, some of the DEmiRNAs overlapped among different comparisons, suggesting that more than 
one variable can influence their expression in stool samples. The highest number of common DEmiRNAs (n = 20) 
was observed between BMI and coffee consumption. However, a group of overlapping DEmiRNAs showed 
opposite trends of expression among different variables, such as those down-regulated with coffee consumption 
but up-regulated with both increasing BMI and physical activity, and other miRNAs up-regulated in smoking 
but down-regulated with increasing BMI.
We also assessed individual inter/intra variability of miRNAs detected in stool by deep sequencing. miR-
647-3p, miR-6075, and miR-320e-5p showed the lowest variability across the population while nine miRNAs 
were consistently detected in all samples. Intra-individual analysis of miRNA expression levels showed a good 
correlation between two samplings performed for six subjects at two time-points, with the second collection 
performed approximately after one year. Also, the nine miRNAs detected in all samples did not report any sig-
nificant difference in mean expression levels when compared between the two time-points. Similarly, assessing 
the overall DEmiRNAs intra-variability in the two time-points, 85.2% of them did not show any significant dif-
ference of expression. Our findings suggest that, in healthy conditions, miRNA expression levels detectable in 
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stool seems to be relatively stable over several months. However, within-stool and within-day stool variability 
are a matter of debate for the validation of biomarkers in this  specimen67.
The present study relies on a large sample size analysed. The subjects involved were all presumably healthy 
at recruitment. Moreover, the availability of the data from the questionnaires for all the individuals enabled a 
consistent statistical analysis with very few missing data. Another strength of this work was the miRNome-wide 
approach which enabled the analysis of all the currently known and expressed miRNAs: the majority of the 
previous studies on this field were, in fact, based on arrays or RT-qPCR methods and thus focused only on a 
limited number of miRNAs.
We are also aware of some limitations: the self-reported information retrieved from the questionnaires may 
contain data entry errors, or individuals may have wrongly answered. Another limitation is the small sample size 
for some of the categories investigated among the variables, such as the obese and underweight groups in the BMI 
analysis, the active category for the physical activity, and non-alcohol consumers. Thus, further investigations in 
an independent cohort with a similar sample size might be helpful to validate/corroborate our results. However, 
it is currently difficult to find another cohort with both stool miRNA profile data and detailed information on 
lifestyle characteristics available.
To conclude, profiles of several miRNAs in stool reflect main common traits and lifestyle habits. These 
findings are also supported by the pathway enrichment analysis results highlighting the involvement of several 
DEmiRNAs in biological processes characterising many of the analysed traits. Some of the observed associations 
confirmed those previously reported in similar studies on other biospecimens while many are hereby observed 
for the first time, supporting the whole miRNome explorative approach. Currently, we cannot state a relation of 
causality between the investigated variables and miRNA profiles, as we cannot rule out the potential for other 
confounding factors. However, considering that a group of DEmiRNAs in our study has already been investigated 
as potential biomarkers in relation to various diseases and  cancers68, 69, we may conclude that the role of the 
described confounders should be carefully considered in studies evaluating the potentiality of faecal miRNAs 
as molecular biomarkers.
Methods
Study population. We collected stool samples from healthy donors participating in different studies run-
ning in our laboratory. Briefly, 132 volunteers were recruited from a study investigating the role of different die-
tary habits described in Tarallo et al.28 (Study 1), 76 individuals were recruited as controls in a study on colorectal 
cancer (i.e., negative at colonoscopy for any colorectal malignancy or polyp, or other gastrointestinal diseases) 
(Study 2)70, and 127 individuals in an association study comparing healthy individuals either on gluten-free diet 
or with no dietary restrictions (Study 3, not published yet).
All subjects provided written informed consent and filled out, at the time of the recruitment, dietary and 
lifestyle questionnaires validated in the European Prospective Investigation into Cancer and Nutrition (EPIC) 
 study71. These latter were deposited in “AcQUE” (https:// kdd. di. unito. it/ epic), an in-house web-tool specifically 
developed for the digital acquisition of questionnaire data.
Local Ethics Committees (Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria and 
Azienda Ospedaliera-Universitaria Città della Salute e della Scienza di Torino, Italy) approved the study.
The present research involving human research participants has been performed in accordance with the 
Declaration of Helsinki. Human participants’ names and other identifiers were removed from all sections of the 
manuscript, including supplementary information.
Sample collection. Naturally evacuated stool samples were collected at home from all participants accord-
ing to the instruction given and using the Norgen Stool Nucleic Acid Collection and Preservation Tubes (Norgen 
Biotek Corp). Samples were brought to the Italian Institute for Genomic Medicine (IIGM) laboratory or to the 
recipient hospital. Faecal samples were aliquoted into Eppendorf LoBind tubes and stored at − 80 °C until use.
Total RNA extraction from stool. Total RNA was extracted from 200 µl faecal aliquots with the Stool 
total RNA purification kit (Norgen Biotek Corp) using the protocol recommended by the manufacturer. RNA 
quality and quantity were verified according to the MIQE guidelines (http:// miqe. gene- quant ifica tion. info/). 
For all samples, RNA concentration was quantified by Qubit fluorometer with a Qubit microRNA assay kit 
(Invitrogen).
Library preparation for small RNA sequencing. Library preparation for sRNA-Seq was performed 
with the NEBNext Multiplex Small RNA Library Prep Set for Illumina (Protocol E7330, New England BioLabs 
Inc., USA; New England BioLabs Inc., USA) as described in Tarallo et al.22. For each sample, 250 ng of RNA was 
used as starting material to prepare libraries.
Each library was prepared with a unique indexed primer so that the libraries could all be pooled into one 
sequencing lane. Multiplex adaptor ligations, reverse transcription primer hybridization, reverse transcription 
reaction, and PCR amplification were performed according to the protocol for library preparation (Protocol 
E7330, New England BioLabs Inc., Ipswich, MA, USA). After PCR amplification, the cDNA constructs were 
purified with the QIAQuick PCR Purification Kit (Qiagen, Germany) following the modifications suggested by 
the NEBNext Multiplex Small RNA Library Prep Protocol and loaded on the Bioanalyzer 2100 (Agilent Tech-
nologies, Milan, Italy) using the DNA High Sensitivity Kit (Agilent, Germany) according to the manufacturer’s 
protocol. Libraries were pooled together (24-plex) and further purified with a gel size selection.
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A final Bioanalyzer 2100 run with the High Sensitivity DNA Kit (Agilent Technologies, Milan, Italy) that 
allows the analysis of DNA libraries regarding size, purity and concentration completed the workflow of library 
preparation.
The obtained sequence libraries (24-samples multiplexed) were subjected to the Illumina sequencing pipeline, 
passing through clonal cluster generation on a single-read flow cell (Illumina Inc., USA) by bridge amplification 
on the cBot (TruSeq SR Cluster Kit v3-cBOT-HS, Illumina Inc., USA) and 50 cycles sequencing-by-synthesis on 
the HiSeq 2000 (Illumina Inc., USA) (in collaboration with Genecore Facility at EMBL, Heidelberg, Germany).
Analysis of miRNAs from sRNA-seq data. A full description of miRNA data analysis is detailed 
 elsewhere70, 72. FastQC software was used to check the quality of Fastq files (http:// www. bioin forma tics. babra 
ham. ac. uk/ proje cts/ fastqc/). Reads shorter than 14 nt were discarded.  Cutadapt73 was used to clip the reads 
that passed the quality control from the adapter sequences by imposing a maximum error rate in terms of 
mismatches, insertions, and deletions equal to 0.15. The length of the raw sRNA-Seq reads was 50 bp. Trimmed 
reads were mapped against an in-house reference of human miRNA sequences composed of 1,917 precursor 
miRNAs from miRBase  v2274. The alignment was performed using BWA algorithm v. 0.7.1275 with the default 
settings. Using these settings, the seeding was not performed for reads shorter than 32 bp, and the reads were 
entirely evaluated for the alignment. miRNAs were annotated and quantified using two methods called the 
“knowledge-based” and “position-based” methods. In the “knowledge-based” method, the arm starting posi-
tions of the miRNA precursors were well defined. Based on the position of the mapped reads, it was possible to 
quantify the mature miRNAs. Alternatively, the “position-based” method was implemented for those miRNA 
precursors in which the positions of the 5p and 3p arms are not defined in miRBase. With the second method, 
based on the position of the read, it was assigned a “-5p” or “-3p” suffix to the name of miRNAs written in Italics 
(to distinguish from the other miRNAs with assigned arms derived from miRBase). The quantification of mature 
miRNA annotations was performed by counting the read alignment reported by BWA output and an overall of 
3,524 miRNAs were analysed. The results generated by the annotation and quantification methods were merged 
into a unique mature miRNA count matrix, composed of 3,524 rows (miRNAs) and 335 columns (samples).
Classification criteria for common traits and lifestyle habits. Information on smoking status, alco-
hol and coffee consumption, and physical activity were collected from the quantitative and qualitative EPIC die-
tary and lifestyle  questionnaires71 whereas individual characteristics (i.e. age, height and weight ) were reported 
in a baseline questionnaire. For women, menopausal status information (premenopausal and postmenopausal) 
was also included in EPIC lifestyle questionnaire.
All the investigated traits were treated as categorical variables in the different comparisons, except for age and 
BMI that were also analysed as continuous variables. According to the distribution of subjects age at recruitment, 
three age classes were defined based on tertiles. BMI was coded according to the World Health Organization 
(WHO) guidelines as normal weight (18.5–24.9 kg/m2), underweight (< 18.5 kg/m2), overweight (25.0–29.9 kg/
m2), and obese (> 30.0 kg/m2) (Table 1).
Self-reported smoking habits were categorized as current, former (all subjects quitted smoking since at least 
one year), and never smokers. Current smokers were further stratified in light (< 16 cigarettes/day (cigs/day)) 
and heavy smokers (≥ 16 cigs/day), according to the median number of cigarettes smoked per day (Table 1). 
Individuals were also categorized by their self-reported alcohol consumption (i.e., gr/day intake of alcohol) in 
non-drinkers (0 gr/day), low intake (0.1–24.0 gr/day for male and 0.1–12.0 gr/day for female), and high intake 
(> 24.0 gr/day for male and > 12.0 gr/day for female) according to WHO guidelines. A similar stratification was 
also adopted according to the coffee consumption: individuals were initially grouped into drinkers and non-
drinkers. The former category was then further stratified in low (< 8.0 gr/day) and high (> 8.0 gr/day) intake 
coffee drinkers according to the median value.
Physical activity was assessed by the total Physical Activity Index (PAI) according to the EPIC guidelines. 
Briefly, for each subject, the PAI was calculated based on the different sources of recreational, household, and 
occupational activities self-reported in the questionnaires. The household and recreational activities were com-
bined with metabolic equivalent intensity values (METs)76 assigned for each activity, to obtain the MET-hours 
per week. Total MET-hours per week were divided into sex-specific quartiles (low, medium, high, and very high) 
and cross-classified with the categories of occupational activity. Finally, each subject was categorized into one of 
the four following groups: inactive, moderately inactive, moderately active, and active.
Statistical and computational analyses. All statistical analyses were performed using R software ver-
sion 4.0.4. The miRNA intra-individual variability was tested by a correlation analysis and a Wilcoxon paired 
test between miRNA expression levels of a subset of subjects who provided samples at two different time points. 
To assess the inter-individual variability of miRNA expression levels the mean absolute deviation (MAD) was 
calculated after filtering out all miRNAs with a median number of normalised reads lower than 1. Then, for each 
miRNA, a coefficient of variation (CV) was obtained as the ratio between the MAD and the median.
Differential expression analyses were performed with the DESeq2 package (v.1.28.1), using the Wald method 
as statistical  test77. Two types of analyses were carried out: the first included all samples, and the second one was 
performed after stratification by sex. Each model was adjusted for potential confounding biological variables 
(age and sex in the full model analysis, only age in the stratified analysis) and for any source of possible batch 
effect (i.e., library pools). A miRNA was defined as significantly differentially expressed if associated with a 
Benjamini–Hochberg adjusted p-value lower than 0.05 and a median number of normalised reads of at least 10 
within at least one of the sample groups considered in the analyses.
13
Vol.:(0123456789)
Scientific Reports |        (2021) 11:20645  | https://doi.org/10.1038/s41598-021-00014-1
www.nature.com/scientificreports/
Correlations between miRNA (only those with a median number of reads ≥ 10) expression levels and age 
or BMI, considered as continuous variables, were calculated using the Spearman’s rank correlation coefficient 
(SCC). Subsequently, miRNAs were classified in three categories, based on their SCC: increasing with age/BMI 
(SCC > 0.2), unaltered (-0.2 < SCC < 0.2) or decreasing with age/BMI (SCC < -0.2) as reported  in10.
For DEmiRNAs associated with the analysed variables, the miRNA target functional enrichment analysis was 
performed with RBiomirGS v0.2.1278, using as input the calculated log2 Fold-change (FC) and adjusted p-value 
from the DE analysis. A detailed description of the analysis is reported  elsewhere79.
Data availability
Raw small RNA sequencing data are available upon request to the authors.
Received: 22 July 2021; Accepted: 5 October 2021
References
 1. Lewandowska, A. M., Rudzki, M., Rudzki, S., Lewandowski, T. & Laskowska, B. Environmental risk factors for cancer—review 
paper. Ann. Agric. Environ. Med. 26, 1–7. https:// doi. org/ 10. 26444/ aaem/ 94299 (2019).
 2. Herceg, Z. Epigenetics and cancer: Towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 22, 
91–103. https:// doi. org/ 10. 1093/ mutage/ gel068 (2007).
 3. Cavalli, G. & Heard, E. Advances in epigenetics link genetics to the environment and disease. Nature 571, 489–499. https:// doi. 
org/ 10. 1038/ s41586- 019- 1411-0 (2019).
 4. Hombach, S. & Kretz, M. Non-coding RNAs: Classification, biology and functioning. Adv. Exp. Med. Biol. 937, 3–17. https:// doi. 
org/ 10. 1007/ 978-3- 319- 42059-2_1 (2016).
 5. Lin, S. & Gregory, R. I. MicroRNA biogenesis pathways in cancer. Nat. Rev. Cancer 15, 321–333. https:// doi. org/ 10. 1038/ nrc39 32 
(2015).
 6. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U S A 105, 
10513–10518, doi:https:// doi. org/ 10. 1073/ pnas. 08045 49105 (2008).
 7. Francavilla, A. et al. Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: A review. Mutagenesis 
35, 243–260. https:// doi. org/ 10. 1093/ mutage/ gez038 (2020).
 8. Meder, B. et al. Influence of the confounding factors age and sex on microRNA profiles from peripheral blood. Clin. Chem. 60, 
1200–1208. https:// doi. org/ 10. 1373/ clinc hem. 2014. 224238 (2014).
 9. Noren Hooten, N. et al. Age-related changes in microRNA levels in serum. Aging (Albany NY) 5, 725–740. https:// doi. org/ 10. 
18632/ aging. 100603 (2013).
 10. Fehlmann, T. et al. Common diseases alter the physiological age-related blood microRNA profile. Nat. Commun. 11, 5958. https:// 
doi. org/ 10. 1038/ s41467- 020- 19665-1 (2020).
 11. Ameling, S. et al. Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study. 
BMC Med. Genomics 8, 61. https:// doi. org/ 10. 1186/ s12920- 015- 0136-7 (2015).
 12. Ortega, F. J. et al. Targeting the circulating microRNA signature of obesity. Clin. Chem. 59, 781–792. https:// doi. org/ 10. 1373/ clinc 
hem. 2012. 195776 (2013).
 13. Schembri, F. et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. 
Natl. Acad. Sci. USA 106, 2319–2324. https:// doi. org/ 10. 1073/ pnas. 08063 83106 (2009).
 14. Takahashi, K. et al. Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. Toxicol. Appl. Pharmacol. 
272, 154–160. https:// doi. org/ 10. 1016/j. taap. 2013. 05. 018 (2013).
 15. Su, M. W. et al. Smoking-related microRNAs and mRNAs in human peripheral blood mononuclear cells. Toxicol. Appl. Pharmacol. 
305, 169–175. https:// doi. org/ 10. 1016/j. taap. 2016. 06. 020 (2016).
 16. Chilton, W. L. et al. Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells. 
PLoS ONE 9, e92088. https:// doi. org/ 10. 1371/ journ al. pone. 00920 88 (2014).
 17. Radom-Aizik, S., Zaldivar, F. P. Jr., Haddad, F. & Cooper, D. M. Impact of brief exercise on circulating monocyte gene and micro-
RNA expression: Implications for atherosclerotic vascular disease. Brain Behav. Immun. 39, 121–129. https:// doi. org/ 10. 1016/j. 
bbi. 2014. 01. 003 (2014).
 18. Ten Berg, P. W. et al. Attending a social event and consuming alcohol is associated with changes in serum microRNA: A before 
and after study in healthy adults. Biomarkers 23, 781–786. https:// doi. org/ 10. 1080/ 13547 50X. 2018. 14991 28 (2018).
 19. Alicandro, G., Tavani, A. & La Vecchia, C. Coffee and cancer risk: A summary overview. Eur. J. Cancer Prev. 26, 424–432. https:// 
doi. org/ 10. 1097/ CEJ. 00000 00000 000341 (2017).
 20. Butt, M. S. & Sultan, M. T. Coffee and its consumption: Benefits and risks. Crit. Rev. Food Sci. Nutr. 51, 363–373. https:// doi. org/ 
10. 1080/ 10408 39090 35864 12 (2011).
 21. Gunter, M. J. et al. Coffee drinking and mortality in 10 European countries: A multinational cohort study. Ann. Intern. Med. 167, 
236–247. https:// doi. org/ 10. 7326/ M16- 2945 (2017).
 22. Tarallo, S. et al. Altered fecal small RNA profiles in colorectal cancer reflect gut microbiome composition in stool samples. mSystems 
https:// doi. org/ 10. 1128/ mSyst ems. 00289- 19 (2019).
 23. Thomas, A. M. et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures 
and a link with choline degradation. Nat. Med. 25, 667–678. https:// doi. org/ 10. 1038/ s41591- 019- 0405-7 (2019).
 24. Sarshar, M., Scribano, D., Ambrosi, C., Palamara, A. T. & Masotti, A. Fecal microRNAs as innovative biomarkers of intestinal 
diseases and effective players in host-microbiome interactions. Cancers (Basel) https:// doi. org/ 10. 3390/ cance rs120 82174 (2020).
 25. Francavilla, A., Tarallo, S., Pardini, B. & Naccarati, A. Fecal microRNAs as non-invasive biomarkers for the detection of colorectal 
cancer: A systematic review. Minerva Biotecnol. 31, 30–42. https:// doi. org/ 10. 23736/ S1120- 4826. 18. 02495-3 (2019).
 26. Dong, J., Tai, J. W. & Lu, L. F. miRNA-Microbiota Interaction in Gut Homeostasis and Colorectal Cancer. Trends Cancer 5, 666–669. 
https:// doi. org/ 10. 1016/j. trecan. 2019. 08. 003 (2019).
 27. Rounge, T. B. et al. Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity. Sci. 
Rep. 8, 17650. https:// doi. org/ 10. 1038/ s41598- 018- 35974-4 (2018).
 28. Tarallo, S. et al. Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals. Gut https:// 
doi. org/ 10. 1136/ gutjnl- 2021- 325168 (2021).
 29. Cui, C. et al. Identification and analysis of human sex-biased MicroRNAs. Genomics Proteom. Bioinform. 16, 200–211. https:// doi. 
org/ 10. 1016/j. gpb. 2018. 03. 004 (2018).
 30. Georgiadis, P. et al. Omics for prediction of environmental health effects: Blood leukocyte-based cross-omic profiling reliably 
predicts diseases associated with tobacco smoking. Sci. Rep. 6, 20544. https:// doi. org/ 10. 1038/ srep2 0544 (2016).
 31. Care, A. et al. Sex disparity in cancer: Roles of microRNAs and related functional players. Cell Death Differ. 25, 477–485. https:// 
doi. org/ 10. 1038/ s41418- 017- 0051-x (2018).
14
Vol:.(1234567890)
Scientific Reports |        (2021) 11:20645  | https://doi.org/10.1038/s41598-021-00014-1
www.nature.com/scientificreports/
 32. Phelps, T., Snyder, E., Rodriguez, E., Child, H. & Harvey, P. The influence of biological sex and sex hormones on bile acid synthesis 
and cholesterol homeostasis. Biol. Sex Differ. 10, 52. https:// doi. org/ 10. 1186/ s13293- 019- 0265-3 (2019).
 33. Hagg, S. & Jylhava, J. Sex differences in biological aging with a focus on human studies. Elife https:// doi. org/ 10. 7554/ eLife. 63425 
(2021).
 34. Hackl, M. et al. miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 9, 291–296. https:// doi. 
org/ 10. 1111/j. 1474- 9726. 2010. 00549.x (2010).
 35. Trayssac, M., Hannun, Y. A. & Obeid, L. M. Role of sphingolipids in senescence: Implication in aging and age-related diseases. J. 
Clin. Invest. 128, 2702–2712. https:// doi. org/ 10. 1172/ JCI97 949 (2018).
 36. Brown, B. A. et al. Aging differentially modulates the Wnt pro-survival signalling pathways in vascular smooth muscle cells. Aging 
Cell 18, e12844. https:// doi. org/ 10. 1111/ acel. 12844 (2019).
 37. Paladino, S., Conte, A., Caggiano, R., Pierantoni, G. M. & Faraonio, R. Nrf2 Pathway in age-related neurological disorders: Insights 
into MicroRNAs. Cell Physiol. Biochem. 47, 1951–1976. https:// doi. org/ 10. 1159/ 00049 1465 (2018).
 38. Mohis, M. et al. Aging-related increase in store-operated Ca(2+) influx in human ventricular fibroblasts. Am. J. Physiol. Heart Circ. 
Physiol. 315, H83–H91. https:// doi. org/ 10. 1152/ ajphe art. 00588. 2017 (2018).
 39. Shao, J. L. et al. Identification of serum exosomal MicroRNA expression profiling in menopausal females with osteoporosis by 
high-throughput sequencing. Curr. Med. Sci. 40, 1161–1169. https:// doi. org/ 10. 1007/ s11596- 020- 2306-x (2020).
 40. Stachowiak, G., Zajac, A., Nowak, M., Stetkiewicz, T. & Wilczynski, J. R. Hemostatic disorders of the menopausal period: The role 
of microRNA. Prz Menopauzalny 14, 144–148. https:// doi. org/ 10. 5114/ pm. 2015. 52155 (2015).
 41. Kodahl, A. R., Zeuthen, P., Binder, H., Knoop, A. S. & Ditzel, H. J. Alterations in circulating miRNA levels following early-stage 
estrogen receptor-positive breast cancer resection in post-menopausal women. PLoS ONE 9, e101950. https:// doi. org/ 10. 1371/ 
journ al. pone. 01019 50 (2014).
 42. Kim, Y. K., Kim, B. & Kim, V. N. Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis. Proc. 
Natl. Acad. Sci. USA 113, 1881–1889. https:// doi. org/ 10. 1073/ pnas. 16025 32113 (2016).
 43. Giardina, S. et al. Changes in circulating miRNAs in healthy overweight and obese subjects: Effect of diet composition and weight 
loss. Clin. Nutr. 38, 438–443. https:// doi. org/ 10. 1016/j. clnu. 2017. 11. 014 (2019).
 44. Shi, H. et al. MiR-143-3p suppresses the progression of ovarian cancer. Am. J. Transl. Res. 10, 866–874 (2018).
 45. Sahami-Fard, M. H., Kheirandish, S. & Sheikhha, M. H. Expression levels of miR-143-3p and -424-5p in colorectal cancer and 
their clinical significance. Cancer Biomark. 24, 291–297. https:// doi. org/ 10. 3233/ CBM- 182171 (2019).
 46. Xia, C., Yang, Y., Kong, F., Kong, Q. & Shan, C. MiR-143-3p inhibits the proliferation, cell migration and invasion of human breast 
cancer cells by modulating the expression of MAPK7. Biochimie 147, 98–104. https:// doi. org/ 10. 1016/j. biochi. 2018. 01. 003 (2018).
 47. Zhang, P. et al. MicroRNA-143a-3p modulates preadipocyte proliferation and differentiation by targeting MAPK7. Biomed. Phar-
macother. 108, 531–539. https:// doi. org/ 10. 1016/j. biopha. 2018. 09. 080 (2018).
 48. Xihua, L. et al. Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the 
insulin-like growth factor 2 receptor. Transl. Res. 205, 33–43. https:// doi. org/ 10. 1016/j. trsl. 2018. 09. 006 (2019).
 49. Park, Y. J., Choe, S. S., Sohn, J. H. & Kim, J. B. The role of glucose-6-phosphate dehydrogenase in adipose tissue inflammation in 
obesity. Adipocyte 6, 147–153. https:// doi. org/ 10. 1080/ 21623 945. 2017. 12883 21 (2017).
 50. Thirunavu, V. et al. Higher body mass index is associated with lower cortical amyloid-beta burden in cognitively normal individuals 
in late-life. J. Alzheimers Dis. 69, 817–827. https:// doi. org/ 10. 3233/ JAD- 190154 (2019).
 51. Babu, N. et al. miRNA and proteomic dysregulation in non-small cell lung cancer in response to cigarette smoke. Microrna 7, 
38–53. https:// doi. org/ 10. 2174/ 22115 36607 66618 01031 65343 (2018).
 52. Advani, J. et al. Long-term cigarette smoke exposure and changes in MiRNA expression and proteome in non-small-cell lung 
cancer. OMICS 21, 390–403. https:// doi. org/ 10. 1089/ omi. 2017. 0045 (2017).
 53. Sopori, M. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2, 372–377. https:// doi. org/ 10. 1038/ nri803 (2002).
 54. Carstens, E. E. & Carstens, M. I. Sensory effects of nicotine and tobacco. Nicotine Tob. Res. https:// doi. org/ 10. 1093/ ntr/ ntab0 86 
(2021).
 55. Tang, X., Sun, L., Wang, G., Chen, B. & Luo, F. RUNX1: A regulator of NF-kB signaling in pulmonary diseases. Curr. Protein Pept. 
Sci. 19, 172–178. https:// doi. org/ 10. 2174/ 13892 03718 66617 10091 11835 (2018).
 56. Santos, S., Mattos, A. A., Guimaraes, M. M., Boger, B. S. & Coral, G. P. Alcohol consumption influences clinical outcome in patients 
admitted to a referral center for liver disease. Ann. Hepatol. 17, 470–475. https:// doi. org/ 10. 5604/ 01. 3001. 0011. 7391 (2018).
 57. Rehm, J. et al. Alcohol as a risk factor for liver cirrhosis: A systematic review and meta-analysis. Drug Alcohol Rev. 29, 437–445. 
https:// doi. org/ 10. 1111/j. 1465- 3362. 2009. 00153.x (2010).
 58. Ibanez, F. et al. Circulating MicroRNAs in extracellular vesicles as potential biomarkers of alcohol-induced neuroinflammation 
in adolescence: Gender differences. Int. J. Mol. Sci. https:// doi. org/ 10. 3390/ ijms2 11867 30 (2020).
 59. Urena-Peralta, J. R., Alfonso-Loeches, S., Cuesta-Diaz, C. M., Garcia-Garcia, F. & Guerri, C. Deep sequencing and miRNA profiles 
in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex. Sci. Rep. 8, 15913. https:// doi. org/ 10. 1038/ 
s41598- 018- 34277-y (2018).
 60. Nakayama, T., Funakoshi-Tago, M. & Tamura, H. Coffee reduces KRAS expression in Caco-2 human colon carcinoma cells via 
regulation of miRNAs. Oncol. Lett. 14, 1109–1114. https:// doi. org/ 10. 3892/ ol. 2017. 6227 (2017).
 61. Romualdo, G. R. et al. The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: 
Involvement of miRNA profile modulation. J. Nutr. Biochem. 85, 108479. https:// doi. org/ 10. 1016/j. jnutb io. 2020. 108479 (2020).
 62. Park, G. H., Song, H. M. & Jeong, J. B. Kahweol from coffee induces apoptosis by upregulating activating transcription factor 3 in 
human colorectal cancer cells. Biomol. Ther. (Seoul) 25, 337–343. https:// doi. org/ 10. 4062/ biomo lther. 2016. 114 (2017).
 63. He, Z. et al. Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res. 63, 4396–4401 
(2003).
 64. Dufresne, S., Rebillard, A., Muti, P., Friedenreich, C. M. & Brenner, D. R. A review of physical activity and circulating miRNA 
expression: Implications in cancer risk and progression. Cancer Epidemiol. Biomark. Prev. 27, 11–24. https:// doi. org/ 10. 1158/ 
1055- 9965. EPI- 16- 0969 (2018).
 65. Lee, E. J. et al. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 14, 35–42. https:// 
doi. org/ 10. 1261/ rna. 804508 (2008).
 66. Rivera-Alvarez, I. et al. A single session of physical activity restores the mitochondrial organization disrupted by obesity in skeletal 
muscle fibers. Life Sci. 256, 117965. https:// doi. org/ 10. 1016/j. lfs. 2020. 117965 (2020).
 67. Du, L. et al. Within-stool and within-day sample variability of fecal calprotectin in patients with inflammatory bowel disease: A 
prospective observational study. J. Clin. Gastroenterol. 52, 235–240. https:// doi. org/ 10. 1097/ MCG. 00000 00000 000776 (2018).
 68. Verdier, J. et al. Faecal micro-RNAs in inflammatory bowel diseases. J. Crohns Colitis 14, 110–117. https:// doi. org/ 10. 1093/ ecco- 
jcc/ jjz120 (2020).
 69. Wohnhaas, C. T. et al. Fecal MicroRNAs show promise as noninvasive Crohn’s disease biomarkers. Crohns Colitis 360 2, otaa003. 
https:// doi. org/ 10. 1093/ crocol/ otaa0 03 (2020).
 70. Ferrero, G. et al. Small non-coding RNA profiling in human biofluids and surrogate tissues from healthy individuals: Description 
of the diverse and most represented species. Oncotarget 9, 3097–3111. https:// doi. org/ 10. 18632/ oncot arget. 23203 (2018).
 71. Riboli, E. et al. European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection. 
Public Health Nutr. 5, 1113–1124. https:// doi. org/ 10. 1079/ PHN20 02394 (2002).
15
Vol.:(0123456789)
Scientific Reports |        (2021) 11:20645  | https://doi.org/10.1038/s41598-021-00014-1
www.nature.com/scientificreports/
 72. Kulkarni, N. et al. Reproducible bioinformatics project: A community for reproducible bioinformatics analysis pipelines. BMC 
Bioinform. 19, 349. https:// doi. org/ 10. 1186/ s12859- 018- 2296-x (2018).
 73. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 3. https:// doi. org/ 10. 
14806/ ej. 17.1. 200 (2011).
 74. Kozomara, A., Birgaoanu, M. & Griffiths-Jones, S. miRBase: From microRNA sequences to function. Nucleic Acids Res. 47, D155–
D162. https:// doi. org/ 10. 1093/ nar/ gky11 41 (2019).
 75. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760. 
https:// doi. org/ 10. 1093/ bioin forma tics/ btp324 (2009).
 76. Ainsworth, B. E. et al. Compendium of physical activities: An update of activity codes and MET intensities. Med. Sci. Sports Exerc. 
32, S498-504. https:// doi. org/ 10. 1097/ 00005 768- 20000 9001- 00009 (2000).
 77. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome 
Biol. 15, 550. https:// doi. org/ 10. 1186/ s13059- 014- 0550-8 (2014).
 78. Zhang, J. & Storey, K. B. RBiomirGS: An all-in-one miRNA gene set analysis solution featuring target mRNA mapping and expres-
sion profile integration. PeerJ 6, e4262. https:// doi. org/ 10. 7717/ peerj. 4262 (2018).
 79. Ferrero, G. et al. Intake of natural compounds and circulating microRNA expression levels: Their relationship investigated in 
healthy subjects with different dietary habits. Front. Pharmacol. 11, 619200. https:// doi. org/ 10. 3389/ fphar. 2020. 619200 (2020).
Acknowledgements
This work was supported by the Italian Institute for Genomic Medicine (IIGM) and Compagnia di San Paolo 
Torino, Italy (to B.P., A.N., S.T., G.P., A.G.), Lega Italiana per La Lotta contro i Tumori (to F.C. and A.N.), the 
Fondazione CRT (Grant number 2017.2025 to F.C. and Grant Number 2019-0450 to R.G.P. and A.I.), the COST 
action TRANSCOLONCAN (CA17118 to A.N., B.P., S.T. and A.F.), the Oncobiome European H2020 research 
project (Grant number 825410 to A.N., S.T., F.C. and B.P.), Fondazione Celiachia (FC) and Associazione Italiana 
Celiachia (AIC) (FELLOWSHIP Francavilla N. 015_FC_20171 to A.F.).
Author contributions
A.N. and B.P. designed the study. G.P.C., D.G.R., G.G., A.F. and S.T. helped and curated the samples collec-
tion. A.G., A.F., G.P., and G.F. performed the statistical and computational analyses. A.I. and R.G.P. developed 
AcQUE database and processed questionnaire data. S.G. performed the nutrient quantification and conversion 
from questionnaires. A.F., A.G., G.P., G.F., S.T., B.P., F.C. and A.N. interpreted the results. A.F., G.P., A.G. wrote 
the manuscript with support from G.F., B.P., and A.N.. All the authors critically reviewed and approved the final 
draft of the manuscript.
Competing interests 
The authors declare no competing interests.
Additional information
Supplementary Information The online version contains supplementary material available at https:// doi. org/ 
10. 1038/ s41598- 021- 00014-1.
Correspondence and requests for materials should be addressed to A.N.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons licence, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
© The Author(s) 2021
